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Abstract: Hemangioma is a benign tumor of vascular origin. Although hemangiomas are observed quite frequently, 
particularly in the skin and soft tissue, the rarity with which they are encountered in the fallopian tube makes 
the present study worth reporting in the literature. Cavernous hemangiomas of the fallopian tube are rare benign 
tumors that have been documented to date as isolated case reports only. Here we demonstrate a rare case of in-
cidentally detected tubal cavernous hemangioma in a 49-year-old woman who underwent hysterectomy with right 
salpingo-oophorectomy for high-grade squamous intraepithelial lesion of the uterine cervix and an endometriotic 
cyst of the right ovary. Histopathological examination of a thickened tubal segment revealed a 1.2-cm relatively well-
circumscribed nodular lesion consisting of dilated cavernous spaces filled with red blood cells. The majority of the 
vessels were thin-walled. The lining endothelium had bland-looking nuclei without cytologic atypia or mitotic figures. 
The tubal epithelium showed no pathological abnormalities. Strong and uniform CD31 and CD34 immunoreactivity 
in the lining endothelial cells confirmed the diagnosis of a benign vascular tumor. We also conducted a thorough 
review of the relevant literature with respect to the epidemiology, clinical manifestation, pathology, immunopheno-
type, and treatment options for hemangiomas arising in the fallopian tube.
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Introduction
Hemangioma is a benign vascular tumor origi-
nating from the endothelial cells that line the 
interior surface of blood vessels [1, 2]. Clinically, 
hemangiomas can manifest with bluish skin 
discoloration and a history of size fluctuation 
[2, 3]. Pain may occur after exercise owing to 
shunting of blood flow away from the surround-
ing tissue into the hemangioma [2, 3]. On imag-
ing, hemangiomas can be seen to contain ser-
pentine vessels, fat, smooth muscle, hemoside- 
rin, and phlebolith [2, 3]. Histologically, heman-
giomas are classified based on the predomi-
nant vascular channel type: capillary, cavern-
ous, arteriovenous, and venous [4, 5]. Cavern- 
ous hemangiomas are found in the skin as well 
as in the liver, kidneys, breast, brain, bone, and 
skeletal muscle. It is morphologically character-
ized by cavern-shaped vascular spaces that are 
much wider than those of capillary hemangio-
ma and are lined with bland endothelial cells.
Hemangioma occurs uncommonly in the female 
genital organs with the exception of the vulva. 
Fallopian tube hemangiomas are rare neo-
plasms; only a few cases have been reported 
to date in the English literature [6-13]. Here we 
describe an unusual case of cavernous heman-
gioma of the fallopian tube that was incidenta- 
lly detected in a postmenopausal woman and 
emphasize its histopathological and immuno-
histochemical features. We also thoroughly re- 
view the clinicopathological features of previ-




A 49-year-old woman was referred from an out-
side hospital with an abnormal cervical punch 
biopsy result of high-grade squamous intraepi-
thelial lesion (HSIL; cervical intraepithelial neo-
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plasia 2). On physical examination, she was 
alert, cooperative, and in no apparent distress. 
She had no symptoms or signs of disease. She 
underwent cervical conization followed by hys-
terectomy with right salpingo-oophorectomy 
and pelvic peritoneal biopsy. The pathological 
diagnosis of the conization specimen was HSIL 
(CIN 2) with endocervical glandular extension. A 
histopathological examination of the resected 
specimens, including the uterus, right adnexa, 
and pelvic peritoneum, was performed.
Histopathological examination
The resected specimens were fixed in 10% neu-
tral-buffered formalin and embedded in paraf-
fin blocks. From each formalin-fixed, paraffin-
embedded (FFPE) block, 4-μm sections were 
cut and stained with hematoxylin and eosin, 
and prepared for immunohistochemical stain-
ing. All slides were examined under routine light 
microscopy by two independent pathologists.
Immunohistochemistry
FFPE sections were deparaffinized and rehy-
drated with a xylene and alcohol solution. Im- 
munohistochemical staining used the Ventana 
Benchmark XT automated staining system (Ve- 
ntana Medical Systems, Inc., Tucson, AZ, USA) 
or Dako Omnis (Dako, Agilent Technologies, 
Inc., Carpinteria, CA, USA) according to the ma- 
nufacturer’s instructions. Antigen retrieval us- 
ed Cell Conditioning Solution (CC1; Ventana 
Medical Systems, Inc.) or EnVision FLEX Target 
Retrieval Solution, High pH (Dako, Agilent Te- 
chnologies, Inc.). Sections were incubated with 
primary antibodies (Table 1). After chromogen-
ic visualization using ultraView Universal DAB 
Detection Kit (Ventana Medical Systems, Inc.) 
or EnVision FLEX/HRP (Dako, Agilent Technolo- 
gies, Inc.), slides were counterstained with he- 
matoxylin and coverslipped. Appropriate posi-
tive and negative controls were stained concur-
rently to validate staining.
Literature review
The Medline database was thoroughly searched 
using the PubMed retrieval service. Searches 
were performed using the key words “fallopian 
tube”, “salpinx”, “hemangioma”, and “cavern-
ous hemangioma”. Eight cases of cavernous 
hemangioma of the fallopian tube were found. 
Table 1. Antibodies used for immunohistochemical staining
Antibody Source Clone Dilution
CK7 Dako, Agilent Technologies, Inc., Carpinteria, CA, USA OV-TL 12/30 1:100
CD31 Dako, Agilent Technologies, Inc., Carpinteria, CA, USA JC70A 1:40
CD34 Dako, Agilent Technologies, Inc., Carpinteria, CA, USA QBEnd 10 1:50
D2-40 Dako, Agilent Technologies, Inc., Carpinteria, CA, USA D2-40 1:50
Desmin Dako, Agilent Technologies, Inc., Carpinteria, CA, USA D33 1:500
Ki-67 Dako, Agilent Technologies, Inc., Carpinteria, CA, USA MIB-1 1:150
CK7: cytokeratin 7.
Figure 1. Histopathological findings of tubal cavernous hemangioma. A. There is a well-circumscribed mass located 
adjacent to the fallopian tube. Double white arrows indicate the tubal mucosa. Two black arrows indicate endome-
triotic foci in the mesosalpinx (left lower corner). B. Note the multiple, dilated vascular channels. Each channel is 
filled with red blood cells. C. The vascular spaces are lined with a single layer of benign endothelial cells, which have 
bland-looking nuclei and scant cytoplasm.
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We reviewed the clinical and pathological fea-
tures of the previous cases in addition to the 
current case.
Results
On macroscopic examination, the uterine cervix 
and endometrium showed no remarkable lesi- 
ons. The right ovary displayed a benign-appear-
ing, thin-walled cystic lesion filled with choco-
late-colored old blood, consistent with an endo-
metriotic cyst. The right fallopian tube had a 
thickened segment in the ampulla. The fimbria 
was unremarkable. The cut surfaces of the 
ampullary mass were hemorrhagic with an area 
that was spongy and irregular and measured 
1.2×0.6 cm. Microscopic examination revealed 
an obvious nodular proliferation of vascular 
channels (Figure 1A) consisting of dilated and 
cavernous blood-filled spaces (Figure 1B). 
These vascular spaces were lined with a single 
layer of endothelial cells (Figure 1C). The indi-
vidual tumor cells had flattened nuclei and 
scant cytoplasm and no cytologic atypia or mi- 
totic figures. No coagulative necrosis was iden-
tified. The tubal epithelium revealed no patho-
logical abnormality. The mesosalpinx and pel-
vic peritoneum showed a few microscopic foci 
of endometriosis.
Immunohistochemical staining for CD31, CD34, 
cytokeratin 7 (CK7), D2-40, desmin, and Ki-67 
was performed. Strong CD31 (Figure 2A) and 
CD34 immunoreactivity in the lining endotheli-
um confirmed the diagnosis of a benign tumor 
of vascular origin. The individual tumor cells 
exhibited uniform membranous expression for 
both vascular endothelial markers (Figure 2B). 
Desmin immunostaining highlighted the tubal 
smooth muscle coat (Figure 2C), but not the 
tumor cells. The tubal mucosa strongly expre- 
ssed CK7 (Figure 2D). The tumor cells were 
negative for desmin, D2-40, and CK7 (Figure 
2E), whereas the epithelial cells lining the tubal 
lumen were highlighted by CK7 (Figure 2F). The 
Ki-67 labeling index was very low (< 1%) in the 
tumor tissue.
The patient made an uneventful postoperative 
recovery and was discharged from the hospital 
6 days after the operation.
Discussion
The pelvic vascular system may include various 
kinds of abnormal vessels in addition to normal 
arterial and venous structures. Abnormally 
dilated vessels and collateral vessel develop-
ment may occur as a result of increased blood 
Figure 2. Immunohistochemical findings of tubal cavernous hemangioma. A. CD31 immunostaining highlights the 
tumor, but not the tubal mucosa and smooth muscle layer. B. A high-power view of image A demonstrates dilated, 
variable-sized, thin-walled vascular spaces. Each tumor cell reveals membranous CD31 immunoreactivity. C. Des-
min immunostaining highlights the tubal smooth muscle layer, but not the tumor. D. The tubal mucosa strongly 
expresses CK7. E. A high-power view of the blue square in image D demonstrates the absence of CK7 expression in 
the tumor cells. F. A high-power view of the red square in image D demonstrates strong and uniform immunoreactiv-
ity for CK7 in the tubal epithelium.
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Table 2. Clinical features of tubal cavernous hemangioma
Case Author (year) Age Side Symptom Imaging finding Clinical impression Associated disease Management
1 Ragins et al. (1947) [6] 28 Left Lower abdominal pain and dysmenorrhea None Tubo-ovarian disease None LSO
2 Talerman (1969) [7] 23 Left Dysmenorrhea None NM (incidental) Mental deficiency LSO+H
3 Ebrahimi et al. (1973) [8] 66 Left Vaginal discharge None NM (incidental) Endometrial cancer BSO+H
4 Patel et al. (1973) [9] 30 Right Right lower quadrant pain None Acute appendicitis Hemoperitoneum RS+A
5 Joglekar et al.(1979) [10] 24 Left Lower abdominal pain None Ovarian cyst torsion Hemoperitoneum LS
6 Atere-Roberts et al. (2010) [11] 14 Right Right lower quadrant pain None Acute appendicitis Hemoperitoneum RS+A
7 Wojnar et al. (2010) [12] 69 Left None None NM (incidental) Endometrial cancer BSO+H
8 Deb et al. (2014) [13] 50 Left Dysmenorrhea A pelvic cystic lesion NM Adenomyosis BSO+H
9 Kim et al. (2016) [The present study] 49 Right None None NM (incidental) Cervical HSIL and tubo-ovarian endometriosis RSO+H
NM: not mentioned; HSIL: high-grade squamous intraepithelial lesion; LSO: left salpingo-oophorectomy; H: hysterectomy; BSO: bilateral salpingo-oophorectomy; RS: right salpingectomy; A: appendectomy; LS: left salpingectomy; RSO: right 
salpingo-oophorectomy.
Table 3. Pathological features of tubal cavernous hemangioma
Case Macroscopic finding Location Size Microscopic finding Immunostaining result
1 A polypoid, dark purple-to-red mass filling the entire lumen Fimbria 1.5 cm Cavernous hemangioma None
2 A small, round, red-to-brown lesion bulging into the lumen Middle-third 0.5 cm Cavernous hemangioma None
3 A slight bulge Mid-portion 0.8 cm Cavernous hemangioma None
4 An encapsulated, slightly transparent, spongy mass with blood-filled cystic spaces Fimbria 3.5 cm Cavernous hemangioma None
5 A dilated lumen filled with blood clot Fimbria 2.0 cm Cavernous hemangioma None
6 A dilated tubal segment with a hemorrhagic mass NM 3.5 cm Cavernous hemangioma None
7 NM NM 0.3 cm Cavernous hemangioma CD34 (P), CD31 (P), EMA (N), LYVE (N)
8 A mixed solid and cystic nodule with congestion Ampulla 3.0 cm Cavernous hemangioma CD34 (P)
9 A thickened tubal segment with blood-filled cystic spaces Ampulla 1.2 cm Cavernous hemangioma CD34 (P), CD31 (P), D2-40 (N)
NM: not mentioned; P: positive; N: negative; EMA: epithelial membrane antigen; LYVE: lymphatic vessel endothelial hyaluronan receptor.
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pressure, stenosis, or abnormal positioning 
(such as stretching, compression, torsion, and 
kinking). The development of vascular lesions 
or pelvic neoplasms can also be involved in the 
vascular dilatation. Among these factors that 
may be involved in the production of dilated 
and cavernous blood vessels, one can elimi-
nate the possibility of torsion or trauma in our 
case since the resected tissue’s viability was 
apparent. The possibility of an association with 
a neoplastic lesion can also be excluded. 
Inflammatory changes characterized by the for-
mation of granulation tissue with increased 
capillarization did not play a role in the tumor 
reported here. In our case, the folds were well 
preserved and the supporting stroma and mus-
cular layer showed no morphological evidence 
of inflammatory infiltrate. In two previous case 
reports, fallopian tube hemangiomas were 
associated with adenocarcinoma of the endo-
metrium [8, 12]. Ebrahimi and Okajaki [8] stat-
ed that hemangioma might be related to the 
female sex hormone and suggested that a 
hemangioma might first develop or rapidly 
increase in size at the onset of menstruation or 
in pregnancy because the numbers, weight, 
and volume of blood vessels increase during 
pregnancy [7]. They also mentioned that the 
co-existence of fallopian tube hemangioma 
and endometrial adenocarcinoma in their pa- 
tient may support the hormonal theory of hem-
angioma development. Similarly, Atere-Roberts 
and colleagues [11] suggested that estrogen 
might play a part in hemangioma growth 
because their patient presented within months 
of menarche. In addition, based on the history 
of preoperative radiation therapy, Ebrahimi and 
Okajaki [8] raised the possibility that radiation 
was one of the incriminating factors in the 
development of tubal hemangioma. However, in 
seven of the nine patients examined here, no 
association was found with endometrial adeno-
carcinoma or other estrogen-related neoplas- 
ms, and two of the seven patients were meno-
pausal women. Moreover, the seven patients 
did not receive radiation therapy. Therefore, it 
is difficult to conclude that female sex hormone 
or prior radiation therapy is involved in the 
development of hemangioma occurring in the 
fallopian tube. Thus, the pathogenesis of tubal 
hemangioma remains unknown.
The lesion described in this case was inciden-
tally identified and produced no specific signs 
or symptoms due to its size and location. 
However, the histopathological features of such 
lesions, if as a rule unequivocal, require differ-
entiation from lymphangioma, vascular leiomy-
oma, mesothelioma, and adenomatoid tumor. 
Immunohistochemical staining can help distin-
guish hemangiomas from histopathological 
mimics. The hemangioma manifests positive 
reactions for vascular endothelial markers 
CD31 and CD34. However, it does not react 
with lymphatic vessel endothelial hyaluronan 
receptor-1, which distinguishes it from lymph-
angioma; epithelial membrane antigen, which 
excludes epithelial origin of the tumor; and 
Ki-67, which excludes the tumor’s proliferative 
nature or malignant transformation. In our 
case, CD31 expression of was documented, 
which, in the absence of Ki-67 expression, 
unequivocally confirmed the diagnosis of a 
benign tumor of vascular origin.
The clinical and pathological features of tubal 
cavernous hemangioma are summarized in 
Tables 2 and 3, respectively. While reviewing 
these nine cases, we observed various fallopi-
an tube hemangioma findings, positions, and 
sizes. In some cases, a hemangioma of the fal-
lopian tube was protruding into the tubal lumen 
or had a polypoid appearance. Similar to hem-
angiomas that may occur in other organs, it 
developed as an encapsulated, spongy mass 
and even appeared as mixed solid and cystic 
nodules. It was also observed as luminal dilata-
tion filled with blood clots, slight bulges, or 
hemorrhagic masses or blood clots from the 
fimbriated end, even when the masses were 
not distinct. The anatomical locations of tumors 
also varied. There were two cases of unknown 
locations, three in the fimbrial region, and four 
in the ampulla and mid-portion. Tumor size was 
0.3-3.5 cm (mean, 1.8 cm; median, 1.5 cm). 
Lesions < 1.0 cm in diameter were all inciden-
tally detected, whereas those > 3.0 cm caused 
hemoperitoneum or a presentation of the cystic 
lesions that grew into the pelvic cavity. In three 
of the nine cases of fallopian tube hemangio-
mas, hemoperitoneum was found during sur-
gery with a blood volume of 100 mL (two cases) 
and 500 mL (one case), respectively. Rupture 
of an undetected fallopian tube hemangioma 
can lead to hemoperitoneum with fatal conse-
quences, and misinterpretation of this benign 
entity in a young woman may lead to radical 
surgery with subsequent loss of fertility. 
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Hemangioma of the fallopian tube can cause 
both rupture-induced hemoperitoneum and tor-
sion, trauma, or inflammation by its mass 
effects.
In summary, the case described here, as in pre-
vious cases, confirms that fallopian tube hem-
angiomas are rare benign lesions. It is neces-
sary to consider hemangioma in the differential 
diagnosis of fallopian tube masses. Proper 
diagnosis can be established only after histo-
pathological examination. Such lesions are 
usually asymptomatic, but torsion, trauma, and 
extensive bleeding with subsequent hemoperi-
toneum can occur. Detailed investigations are 
necessary to clarify the pathogenesis of tumor 
development and growth of hemangioma in the 
fallopian tube.
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